Cargando…

Targeted therapies in rheumatoid arthritis: Focus on rituximab

B-cell depletion is a new strategy for treating patients with rheumatoid arthritis (RA). In the past years, several studies have proven the efficacy of anti-CD20 mediated B-cell depletion with rituximab (Mabthera(®)) in RA patients who failed TNF-blocking therapy. The important role of B-cells in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, YKO, Huizinga, TWJ, van Laar, JM
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721296/
https://www.ncbi.nlm.nih.gov/pubmed/19707303

Ejemplares similares